Aptevo Therapeutics, Inc. (APVO)
1.16
-0.04
(-3.33%)
USD |
NASDAQ |
Dec 11, 16:00
1.14
-0.02
(-1.72%)
After-Hours: 06:58
Aptevo Therapeutics EPS Diluted (Quarterly): -2.230 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Salarius Pharmaceuticals, Inc. | -1.814 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
| Oragenics, Inc. | -1.965 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -9.028M |
| Total Expenses (Quarterly) | 9.028M |
| Enterprise Value | -13.33M |
| Earnings Yield | -15.95K% |
| Normalized Earnings Yield | -15953.98 |